AorTech International has received a material milestone payment from St Jude Medical related to the licensing and supply agreement announced on 20 July 2006.
Subscribe to our email newsletter
The milestone payment extends the exclusive use of Elast-Eon 2 in the field of cardiac pacing, ICD (implantable cardiac defibrillator) and cardiac monitoring leads into perpetuity. One further optional milestone payment, contingent on the issue of new AorTech polymer intellectual property, would occur sometime in the fourth quarter of 2009.
Frank Maguire, AorTech CEO said, “The partnership with St Jude Medical has been a productive one and we look to the growth of this relationship in the future. This payment forms part of management expectations for revenue in 2008.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.